Sign in Pull a receipt

HOWL

Werewolf Therapeutics, Inc.

Healthcare · Biotechnology

$251.98 sample

-3.82 (-1.49%) 1D

Market cap

$537.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-09

Alerts

8

Price$251.98 +0.66% 3M daily closessample

265.45238.00

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19INSInsider buy: EVP, Operations
Oct 14INSInsider sell: 10% owner
Oct 09INSInsider buy: Director
Sep 30INSInsider sell: EVP, Operations
Sep 25INSInsider buy: General Counsel
Sep 17INSInsider sell: 10% owner
Sep 09SECForm 144 filed
Sep 03INSInsider sell: Chief Executive Officer

Sign up to see the real HOWL record →

Company facts

SEC EDGAR registration

Name: Werewolf Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +58sample, -100 to +100
Reporting currency: USD

Who is positioning in HOWL

sample

Insiders: 15 insider transactions over 90 days, net selling, $533.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 27 funds hold $4.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.3B +10.1% y/y

Q4 2024Q3 2026

Inventory$11.6B +11.5% y/y

Q4 2024Q3 2026

Accounts receivable$8.6B +19.7% y/y

Q4 2024Q3 2026

Total debt$22.6B +18.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $252.1B +11.5% 3M
Sample peer B: $516.1B +2.5% 3M
Sample peer C: $510.9B +8.8% 3M
Sample peer D: $181.2B -13.0% 3M
Sample peer E: $69.0B +4.9% 3M